Structure of the human Duffy antigen receptor

The Duffy antigen receptor, also known as FY glycoprotein or CD234, is a seven transmembrane protein expressed primarily at the surface of red blood cells, which displays promiscuous binding to multiple chemokines. Not only does it serve as the basis of the Duffy blood group system but it also acts as the primary attachment site for malarial parasite Plasmodium vivax on erythrocytes and as one of the nucleating receptors for the pore forming toxins secreted by Staphylococcus aureus. Despite a predicted 7TM architecture and efficient binding to a spectrum of chemokines, it fails to exhibit canonical second messenger response such as calcium release, likely due to a lack of G protein coupling. Unlike prototypical GPCRs and β-arrestin-biased atypical chemokine receptors, the Duffy antigen receptor also appears to lack β-arrestin binding, making it an enigmatic 7TM chemokine receptor. In order to decipher the molecular mechanism of this intriguing functional divergence exhibited by the Duffy antigen receptor, we have determined its cryo-EM structure in complex with a C-C type chemokine, CCL7. The structure reveals a relatively superficial binding mode of CCL7, with the N-terminus of the receptor serving as the key interaction interface, and a partially formed orthosteric binding pocket lacking the second site for chemokine recognition compared to prototypical chemokine receptors. The structural framework allows us to employ HDX-MS approach to uncover ligand-induced structural changes in the receptor and draw important insights into the promiscuous nature of chemokine binding. Interestingly, we also observe a dramatic shortening of TM5 and 6 on the intracellular side, compared to prototypical GPCRs, which precludes the coupling of canonical signal-transducers namely G proteins, GRKs and β-arrestins, as demonstrated through extensive cellular assays. Taken together, our study uncovers a previously unknown structural mechanism that imparts unique functional divergence on the 7TM fold encoded in the Duffy antigen receptor while maintaining its scavenging function and should facilitate the designing of novel therapeutics targeting this receptor.

[1]  M. Chami,et al.  Structural snapshots uncover a key phosphorylation motif in GPCRs driving β-arrestin activation. , 2023, Molecular cell.

[2]  B. Volkman,et al.  Prospects for targeting ACKR1 in cancer and other diseases , 2023, Frontiers in Immunology.

[3]  E. Lowe,et al.  Structural basis for DARC binding in reticulocyte invasion by Plasmodium vivax , 2023, bioRxiv.

[4]  S. Scheres,et al.  A Bayesian approach to single-particle electron cryo-tomography in RELION-4.0 , 2022, bioRxiv.

[5]  T. Schall,et al.  Structures of atypical chemokine receptor 3 reveal the basis for its promiscuity and signaling bias , 2022, Science advances.

[6]  D. Sengupta,et al.  Insights into the dynamic interactions at chemokine-receptor interfaces and mechanistic models of chemokine binding. , 2022, Journal of Structural Biology.

[7]  Qiang Zhao,et al.  Activation of the human chemokine receptor CX3CR1 regulated by cholesterol , 2022, Science advances.

[8]  H. Xu,et al.  Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3 , 2022, Cell discovery.

[9]  M. Ueda,et al.  Heterotrimeric Gq proteins act as a switch for GRK5/6 selectivity underlying β-arrestin transducer bias , 2022, Nature communications.

[10]  D. Devost,et al.  Allosteric modulation of GPCR-induced β-arrestin trafficking and signaling by a synthetic intrabody , 2022, Nature Communications.

[11]  H. Xu,et al.  Identification and mechanism of G protein-biased ligands for chemokine receptor CCR1 , 2021, Nature Chemical Biology.

[12]  B. Volkman,et al.  The dimeric form of CXCL12 binds to atypical chemokine receptor 1 , 2021, Science Signaling.

[13]  Oriol Vinyals,et al.  Highly accurate protein structure prediction with AlphaFold , 2021, Nature.

[14]  P. Andrews,et al.  Structures of rhodopsin in complex with G-protein-coupled receptor kinase 1 , 2021, Nature.

[15]  Yechun Xu,et al.  Structural basis for chemokine recognition and receptor activation of chemokine receptor CCR5 , 2021, Nature Communications.

[16]  T. Woodruff,et al.  Intrinsic bias at non-canonical, β-arrestin-coupled seven transmembrane receptors , 2021, bioRxiv.

[17]  S. Grzesiek,et al.  Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist , 2020, Science Advances.

[18]  C. Day,et al.  Identification of a domain critical for Staphylococcus aureus LukED receptor targeting and lysis of erythrocytes , 2020, The Journal of Biological Chemistry.

[19]  Conrad C. Huang,et al.  UCSF ChimeraX: Structure visualization for researchers, educators, and developers , 2020, Protein science : a publication of the Protein Society.

[20]  Suwen Zhao,et al.  Structural basis of CXC chemokine receptor 2 activation and signalling , 2020, Nature.

[21]  M. Ammirati,et al.  Structural basis for chemokine receptor CCR6 activation by the endogenous protein ligand CCL20 , 2020, Nature Communications.

[22]  J Gomez-Blanco,et al.  DeepEMhancer: a deep learning solution for cryo-EM volume post-processing , 2020, Communications Biology.

[23]  T. Woodruff,et al.  Emerging Insights into the Structure and Function of Complement C5a Receptors. , 2020, Trends in biochemical sciences.

[24]  Sjors H W Scheres,et al.  Estimation of high-order aberrations and anisotropic magnification from cryo-EM data sets in RELION-3.1 , 2020, IUCrJ.

[25]  P. Ligthart,et al.  Differential interaction between DARC and SDF-1 on erythrocytes and their precursors , 2019, Scientific Reports.

[26]  Randy J. Read,et al.  Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix , 2019, Acta crystallographica. Section D, Structural biology.

[27]  M. V. Goncharuk,et al.  Purification of native CCL7 and its functional interaction with selected chemokine receptors , 2019, bioRxiv.

[28]  Lei Xu,et al.  Cytokine Levels in Inner Ear Fluid of Young and Aged Mice as Molecular Biomarkers of Noise-Induced Hearing Loss , 2019, Front. Neurol..

[29]  K. Chung,et al.  Conformational sensors and domain-swapping reveal structural and functional differences between β-arrestin isoforms , 2019, bioRxiv.

[30]  R. Russell,et al.  Illuminating G-Protein-Coupling Selectivity of GPCRs , 2019, Cell.

[31]  R. Cheng,et al.  Crystal Structure of CC Chemokine Receptor 2A in Complex with an Orthosteric Antagonist Provides Insights for the Design of Selective Antagonists. , 2019, Structure.

[32]  P. Loke,et al.  Staphylococcus aureus Leukocidins Target Endothelial DARC to Cause Lethality in Mice. , 2019, Cell host & microbe.

[33]  T. Woodruff,et al.  Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1 , 2019, The Journal of Biological Chemistry.

[34]  Erik Lindahl,et al.  New tools for automated high-resolution cryo-EM structure determination in RELION-3 , 2018, eLife.

[35]  W. Weis,et al.  The Molecular Basis of G Protein-Coupled Receptor Activation. , 2018, Annual review of biochemistry.

[36]  R. Abagyan,et al.  Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV , 2017, Immunity.

[37]  P. Moss,et al.  Atypical chemokine receptor 1 on nucleated erythroid cells regulates hematopoiesis , 2017, Nature Immunology.

[38]  David J. Fleet,et al.  cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination , 2017, Nature Methods.

[39]  Ruben Abagyan,et al.  Structure of CC Chemokine Receptor 2 with Orthosteric and Allosteric Antagonists , 2016, Nature.

[40]  C. Day,et al.  Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes. , 2015, Cell host & microbe.

[41]  R. Couñago,et al.  Structures of Orf Virus Chemokine Binding Protein in Complex with Host Chemokines Reveal Clues to Broad Binding Specificity. , 2015, Structure.

[42]  R. Horuk.  The Duffy Antigen Receptor for Chemokines DARC/ACKR1 , 2015, Front. Immunol..

[43]  Maria F. Sassano,et al.  PRESTO-TANGO: an open-source resource for interrogation of the druggable human GPCR-ome , 2015, Nature Structural &Molecular Biology.

[44]  Q. Hamid,et al.  CXCL1 Inhibits Airway Smooth Muscle Cell Migration through the Decoy Receptor Duffy Antigen Receptor for Chemokines , 2014, The Journal of Immunology.

[45]  A. Mantovani,et al.  International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors , 2014, Pharmacological Reviews.

[46]  R. Nibbs,et al.  Immune regulation by atypical chemokine receptors , 2013, Nature Reviews Immunology.

[47]  E. Borroni,et al.  Atypical chemokine receptors: from silence to sound. , 2013, Biochemical Society transactions.

[48]  A. Mantovani,et al.  The biochemistry and biology of the atypical chemokine receptors. , 2012, Immunology letters.

[49]  N. Tolia,et al.  Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC , 2011, Nature Structural &Molecular Biology.

[50]  Maria H. Ulvmar,et al.  Atypical chemokine receptors , 2011, Experimental cell research.

[51]  A. G. Brevern,et al.  A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines , 2010, Cellular and Molecular Life Sciences.

[52]  B. Adams.  Faculty Opinions recommendation of Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7. , 2010 .

[53]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[54]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[55]  M. Landrum,et al.  The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry. , 2009, Blood.

[56]  Hassan Belrhali,et al.  Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain , 2006, Nature.

[57]  Priyabrata Pattnaik,et al.  Receptor-binding residues lie in central regions of Duffy-binding-like domains involved in red cell invasion and cytoadherence by malaria parasites. , 2005, Blood.

[58]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[59]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[60]  L. Gardner,et al.  The human Duffy antigen binds selected inflammatory but not homeostatic chemokines. , 2004, Biochemical and biophysical research communications.

[61]  M. Monden,et al.  A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions. , 2003, International immunology.

[62]  C. Chitnis,et al.  Definition of structural elements in Plasmodium vivax and P. knowlesi Duffy-binding domains necessary for erythrocyte invasion. , 2003, The Biochemical journal.

[63]  J. Zagury,et al.  Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC). , 1998, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[64]  L. Schweitzer,et al.  Expression of chemokine receptors by subsets of neurons in the central nervous system. , 1997, Journal of immunology.

[65]  Zhaohua Lu,et al.  The Duffy antigen receptor for chemokines: structural analysis and expression in the brain , 1996, Journal of leukocyte biology.

[66]  T. Schall,et al.  Chemokine Class Differences in Binding to the Duffy Antigen-Erythrocyte Chemokine Receptor (*) , 1995, The Journal of Biological Chemistry.

[67]  R. Horuk,et al.  The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor , 1995, The Journal of experimental medicine.

[68]  R. Horuk,et al.  Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. , 1994, The Journal of clinical investigation.

[69]  K. Williams,et al.  Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[70]  C. Chitnis,et al.  A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. , 1993, Science.

[71]  T. Schall,et al.  Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. , 1993, The Journal of biological chemistry.

[72]  J. Ramachandran,et al.  Structure and Function of G Protein Coupled Receptors , 1990, Pharmaceutical Research.

[73]  L. Miller,et al.  The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. , 1976, The New England journal of medicine.

[74]  P. Mollison,et al.  The Duffy blood group system , 1950, Heredity.

[75]  A. Shukla,et al.  In-cellulo chemical cross-linking to visualize protein-protein interactions. , 2022, Methods in cell biology.

[76]  P. Yadav,et al.  Tango assay for ligand-induced GPCR-β-arrestin2 interaction: Application in drug discovery. , 2016, Methods in cell biology.

[77]  L. F. Kolakowski,et al.  Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. , 1994, Blood.